These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 19916299

  • 1. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
    Feldman SR, Koo JY, Johnson LA, Preston NJ.
    Cutis; 2009 Oct; 84(4 Suppl):25-32. PubMed ID: 19916299
    [Abstract] [Full Text] [Related]

  • 2. The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasis.
    Lebwohl M, Colón LE.
    Cutis; 2007 Nov; 80(5 Suppl):29-40. PubMed ID: 18154221
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis.
    Jarratt MT, Clark SD, Savin RC, Swinyer LJ, Safley CF, Brodell RT, Yu K.
    Cutis; 2006 Nov; 78(5):348-54. PubMed ID: 17186795
    [Abstract] [Full Text] [Related]

  • 4. Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial.
    Menter A.
    Cutis; 2007 Nov; 80(5 Suppl):12-9. PubMed ID: 18154219
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: add-on therapy in the COBRA trial.
    Feldman SR.
    Cutis; 2007 Nov; 80(5 Suppl):20-8. PubMed ID: 18154220
    [Abstract] [Full Text] [Related]

  • 6. Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial.
    Sofen H, Hudson CP, Cook-Bolden FE, Preston N, Colón LE, Colón LE, Caveney SW, Gottschalk RW.
    J Drugs Dermatol; 2011 Aug; 10(8):885-92. PubMed ID: 21818510
    [Abstract] [Full Text] [Related]

  • 7. Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.
    Menter A.
    Cutis; 2012 Feb; 89(2):89-94. PubMed ID: 22474733
    [Abstract] [Full Text] [Related]

  • 8. Relevance of the COBRA trial in current psoriasis practice.
    Koo JY.
    Cutis; 2007 Nov; 80(5 Suppl):4-11. PubMed ID: 18154218
    [Abstract] [Full Text] [Related]

  • 9. An open-label, multicenter study of the efficacy and safety of a weekday/weekend treatment regimen with calcitriol ointment 3 microg/g and clobetasol propionate spray 0.05% in the management of plaque psoriasis.
    Hudson CP, Kempers S, Menter A, Papp K, Smith S, Sofen H, Colón LE, Johnson LA, Gottschalk R.
    Cutis; 2011 Oct; 88(4):201-7. PubMed ID: 22106730
    [Abstract] [Full Text] [Related]

  • 10. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis.
    Beutner K, Chakrabarty A, Lemke S, Yu K.
    J Drugs Dermatol; 2006 Apr; 5(4):357-60. PubMed ID: 16673804
    [Abstract] [Full Text] [Related]

  • 11. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A, Abramovits W, Colón LE, Johnson LA, Gottschalk RW.
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [Abstract] [Full Text] [Related]

  • 12. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
    Lebwohl MG, Kircik L, Callis Duffin K, Pariser D, Hooper M, Wenkert D, Thompson EH, Yang J, Kricorian G, Koo J.
    J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
    [Abstract] [Full Text] [Related]

  • 13. A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg/g ointment in the management of plaque psoriasis.
    Brodell RT, Bruce S, Hudson CP, Weiss JS, Colón LE, Johnson LA, Gottschalk RW.
    J Drugs Dermatol; 2011 Feb; 10(2):158-64. PubMed ID: 21283920
    [Abstract] [Full Text] [Related]

  • 14. Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasis.
    Menter MA, Caveney SW, Gottschalk RW.
    J Drugs Dermatol; 2012 Nov; 11(11):1348-54. PubMed ID: 23135087
    [Abstract] [Full Text] [Related]

  • 15. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS, Keil KA, Mellen BG, McCarty MA, Fleischer AB, Feldman SR.
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [Abstract] [Full Text] [Related]

  • 16. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.
    Kimball AB, Gold MH, Zib B, Davis MW, Clobetasol Propionate Emulsion Formulation Foam Phase III Clinical Study Group.
    J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358
    [Abstract] [Full Text] [Related]

  • 17. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.
    Decroix J, Pres H, Tsankov N, Poncet M, Arsonnaud S.
    Cutis; 2004 Sep; 74(3):201-6. PubMed ID: 15499763
    [Abstract] [Full Text] [Related]

  • 18. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J, Bjerke JR, Gjertsen BT, Helland S, Livden JK, Morken T, Mørk NJ.
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [Abstract] [Full Text] [Related]

  • 19. Improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray.
    Brodell R, Preston N.
    J Drugs Dermatol; 2012 Dec; 11(12):1455-9. PubMed ID: 23377516
    [Abstract] [Full Text] [Related]

  • 20. An open-label, multicenter study of the efficacy and safety of an AM/PM treatment regimen with clobetasol propionate spray 0.05% and calcitriol ointment 3 microg/g in the management of plaque psoriasis.
    Menter A, Sofen H, Smith S, Papp K, Kempers S, Hudson CP, Colón LE, Johnson LA, Gottschalk R.
    Cutis; 2011 Jul; 88(1):46-51. PubMed ID: 21877508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.